Antiepileptic drug exposure during pregnancy has been associated with an increased risk for congenital malformations and delayed cognitive development in the offspring,
1-3 but little is known about the risk of other serious neuropsychiatric disorders. Autistic symptoms have been described in case series of children exposed in utero to valproic acid,
4-7 and it has been suggested that valproate given to animals during pregnancy may constitute an experimental model of autism.
8-10